Stefania Pizzimenti Selected Research

Autoimmune Diseases (Autoimmune Disease)

6/2015

Role of 4-hydroxynonenal-protein adducts in human diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefania Pizzimenti Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 09/2004
6	Melanoma (Melanoma, Malignant) 01/2022 - 12/2013
5	Inflammation (Inflammations) 10/2021 - 11/2008
5	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 01/2018
4	Colonic Neoplasms (Colon Cancer) 01/2012 - 06/2007
3	Skin Neoplasms (Skin Cancer) 01/2021 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2011
3	Atherosclerosis 01/2015 - 11/2008
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2018 - 05/2009
2	Neoplasm Metastasis (Metastasis) 01/2016 - 03/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Carcinogenesis 08/2020
1	Cardiotoxicity 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Metabolic Bone Diseases (Osteopenia) 07/2018
1	Sarcopenia 07/2018
1	Anaplastic Thyroid Carcinoma 11/2017
1	Drug-Related Side Effects and Adverse Reactions 11/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016
1	Autoimmune Diseases (Autoimmune Disease) 06/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Hemorrhage 10/2011
1	Cardiomyopathies (Cardiomyopathy) 10/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011
1	Atherosclerotic Plaque (Atheroma) 10/2011
1	Neointima 10/2011
1	Carcinoma (Carcinomatosis) 09/2010

Drug/Important Bio-Agent (IBA)

13	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2019 - 09/2004
8	Pharmaceutical PreparationsIBA 03/2021 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2005
5	AntioxidantsIBA 10/2021 - 01/2016
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 03/2010
4	AldehydesIBA 07/2018 - 11/2008
4	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2010 - 05/2006
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2019
3	CyclodextrinsIBA 11/2017 - 12/2013
3	Rosiglitazone (Avandia)FDA Link 01/2012 - 06/2007
3	LigandsIBA 01/2012 - 06/2007
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 10/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
2	ailanthoneIBA 01/2020 - 03/2019
2	AntibodiesIBA 01/2019 - 01/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2017 - 01/2016
2	CamptothecinIBA 11/2017 - 01/2016
2	1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA 01/2012 - 01/2012
2	PPAR gammaIBA 06/2010 - 06/2007
1	NF-E2-Related Factor 2IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	CarbohydratesIBA 10/2021
1	LipidsIBA 10/2021
1	Deubiquitinating EnzymesIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	Dendrimers (Dendrons)IBA 10/2020
1	Biological ProductsIBA 10/2020
1	Guanidine (Guanidine Nitrate)FDA Link 10/2020
1	carbosilaneIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2020
1	AnthracyclinesIBA 01/2020
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2018
1	MetalsIBA 01/2017
1	DNA AdductsIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2016
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 02/2016
1	Mitochondrial DNA (mtDNA)IBA 02/2016
1	AlkaloidsIBA 01/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2016
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Cystine (L-Cystine)IBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	AntiportersIBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	AntigensIBA 01/2016
1	NanocapsulesIBA 12/2015
1	Sunitinib (Sutent)FDA Link 01/2015
1	Axitinib (AG 013736)IBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	CrizotinibIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2015
1	Fibric Acids (Fibrates)IBA 01/2012
1	ciprofibrateIBA 01/2012
1	Clofibrate FDA Link 01/2012
1	Thromboplastin (Tissue Factor)IBA 10/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	PanobinostatIBA 01/2011

Therapy/Procedure

11	Therapeutics 12/2021 - 10/2011
1	Topical Administration 12/2015
1	Heart Transplantation (Grafting, Heart) 10/2011